The Bet Protein Inhibitor Apabetalone Rescues Diabetes Induced Impairment of Angiogenic Response

被引：0
|
作者：
Mohammed, Shafeeq Ahmed A.
Albiero, Mattia
Ambrosini, Samuele
Gergely, Karsai
Wenzl, Florian
Gorica, Era
Calderone, Vincenzo
Madeddu, Paolo
Spinetti, Gaia
Luscher, Thomas F.
Costantino, Sarah
Fadini, Gian P.
Paneni, Francesco
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10474
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The BET Protein Inhibitor Apabetalone Rescues Diabetes-Induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
    Mohammed, Shafeeq A.
    Albiero, Mattia
    Ambrosini, Samuele
    Gorica, Era
    Karsai, Gergely
    Caravaggi, Carlo M.
    Masi, Stefano
    Camici, Giovanni G.
    Wenzl, Florian A.
    Calderone, Vincenzo
    Madeddu, Paolo
    Sciarretta, Sebastiano
    Matter, Christian M.
    Spinetti, Gaia
    Luscher, Thomas F.
    Ruschitzka, Frank
    Costantino, Sarah
    Fadini, Gian Paolo
    Paneni, Francesco
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2022, 36 (10) : 667 - 684
  • [2] The BET protein inhibitor apabetalone (RVX-208) restores angiogenic response in type 1 and type 2 diabetes by transcriptional regulation of thrombospondin-1
    Mohammed, S.
    Mattia, M. A.
    Gergely, G. K.
    Gaia, G. S.
    Ambrosini, S. A.
    Paolo, P. M.
    Thomas, T. F. L. F.
    Sarah, S. C.
    Paolo, G. P. F. Gian
    Francesco, F. P.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 3384 - 3384
  • [3] Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
    Brandts, Julia
    Ray, Kausik K.
    [J]. FUTURE CARDIOLOGY, 2020, 16 (05) : 385 - 395
  • [4] BET Protein Inhibitor Apabetalone Suppresses Inflammatory Hyperactivation of Monocytes From Patients With Cardiovascular Disease and Type 2 Diabetes
    Wasiak, Sylwia
    Dzobo, Kim
    Rakai, Brooke
    Kaiser, Yannick
    Versloot, Miranda
    Bahjat, Mahnoush
    Stotz, Stephanie
    Fu, Li
    Sweeney, Michael
    Johansson, Jan
    Wong, Norman
    Stroes, Erik
    Kroon, Jeffrey
    Kulikowski, Ewelina
    [J]. CIRCULATION, 2020, 142
  • [5] THE BET PROTEIN INHIBITOR APABETALONE REDUCES CONGESTIVE HEART FAILURE INCIDENCE IN PATIENTS WITH ACUTE CORONARY SYNDROME AND DIABETES: RESULTS FROM THE BETONMACE TRIAL
    Sweeney, Michael
    Nicholls, Stephen J.
    Ray, Kausik Kumar
    Buhr, Kevin
    Ginsberg, Henry
    Johansson, Jan
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter
    Wong, Norman
    Schwartz, Gregory G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 168 - 168
  • [6] Targeting the histone methyltransferase SETD7 rescues diabetes-induced impairment of angiogenic response by transcriptional repression of semaphorin 3G
    Mohammed, S. A.
    Hoxha, E.
    Albiero, M.
    Karsai, G.
    Masi, S.
    Mengozzi, A.
    Spinetti, G.
    Ruschitzka, F.
    Fadini, G. P.
    Costantino, S.
    Paneni, F.
    [J]. CARDIOVASCULAR RESEARCH, 2024, 120
  • [7] Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes
    Ray, K. K.
    Nicholls, S. J.
    Buhr, K. A.
    Ginsberg, H. N.
    Kalantar-Zadeh, K.
    Johansson, J. O.
    Kulikowski, E.
    Toth, P. P.
    Wong, N.
    Sweeney, M.
    Schwartz, G. G.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 1425 - 1425
  • [8] Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Ginsberg, Henry D.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Cummings, Jeffrey L.
    Sweeney, Michael
    Schwartz, Gregory G.
    [J]. AMERICAN HEART JOURNAL, 2019, 217 : 72 - 83
  • [9] Cardiovascular Evaluation of the Selective BET Inhibitor, Apabetalone, in ACS Patients With Diabetes: Baseline Characteristics of the BETonMACE CV Outcomes Study
    Ray, Kausik K.
    Nicholls, Stephen J.
    Sweeney, Mike
    Johansson, Jan O.
    Toth, Peter P.
    Ginsberg, Henry
    Kalantar-Zadeh, Kamyar
    Schwartz, Gregory G.
    [J]. CIRCULATION, 2018, 138
  • [10] Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants
    Fu, L.
    Gilham, D.
    Stotz, S.
    Sarsons, C.
    Rakai, B.
    Tsujikawa, L.
    Wasiak, S.
    Johansson, J.
    Sweeney, M.
    Wong, N.
    Kulikowski, E.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1696 - 1696
12345